ப்ரிஸிஶந் மருந்தியல் சிகிச்சை ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from PR Newswire. The AP news staff was not involved in its creation. New Study Predicts Risks of Drug Interactions without Exposing Patients to Harm May 11, 2021 GMT (PRNewsfoto/Tabula Rasa HealthCare) MOORESTOWN, N.J., May 11, 2021 /PRNewswire/ Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medication, and Regence Health Plans today announced the results of a simulation-based clinical study which demonstrates that TRHC’s MedWise® medication risk score can be used to assess drug safety without exposing real people to actual harm. The study, published online in Clinical and Translational Science, used TRHC’s proprietary MedWise medications safety technology to virtually assess the potential risk of adverse drug events (ADEs) when adding repurposed drugs for COVID-19 treatment to the individual medications of a large-scale population. The results demonstrate that medication r

United statesVeronique michaudCalvinh knowltonMatthew hafermannRegence health planTabula rasa healthcare incRegence healthPrnewswire tabula rasa healthcare incDevelopment institutePrecision pharmacotherapy researchBlue shield associationRasa healthcareRegence health plansTranslational scienceMedwise risk scoreChief operating officer